File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jgo.2022.02.014
- Scopus: eid_2-s2.0-85125894349
- WOS: WOS:000851360600018
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A pilot randomized controlled trial using Baduanjin qigong to reverse frailty status among post-treatment older cancer survivors
Title | A pilot randomized controlled trial using Baduanjin qigong to reverse frailty status among post-treatment older cancer survivors |
---|---|
Authors | |
Issue Date | 2022 |
Citation | Journal of Geriatric Oncology, 2022, v. 13, p. 682-690 How to Cite? |
Abstract | Objectives: To evaluate the feasibility and potential effects of qigong Baduanjin for reversing frailty status among older cancer survivors. Materials and Methods: Twenty-eight older cancer survivors screened as pre-frail or frail were recruited. They were randomly assigned (1:1) to receive a sixteen-week Baduanjin intervention or an active control condition (light flexibility exercise). Frailty status (primary outcome) and secondary outcomes (physical performance, activities of daily living performance, psychological well-being, and health-related quality of life) were measured by physical performance tests and questionnaires. Qualitative interviews were conducted to explore participants' perspectives on the intervention. Results: Twenty-one participants (75%) completed the study, with reasons of withdrawal mainly relating to the COVID-19 pandemic. Attendance at Baduanjin sessions and adherence to self-practice were satisfactory, with all retained participants attending all sessions and 81.8% practicing Baduanjin for more than 90 min per week. Qualitative findings demonstrated that participants accepted Baduanjin. The proportion of improvement in frailty status at post-intervention appeared to be higher in the intervention group (26.7%; 95% confidence interval [CI], 10.1% to 54.0%) than the control group (15.4%; 95% CI, 3.7% to 46.0%); yet the difference was not statistically significant (p = 0.461). Conclusions: Baduanjin qigong appears to be feasible and acceptable among older cancer survivors. To confirm the intervention effect, an adequately powered trial is warranted. Trial Registration: ClinicalTrials.gov, NCT04694066. Retrospectively registered 5 January 2021, https://clinicaltrials.gov/ct2/show/NCT04694066. |
Persistent Identifier | http://hdl.handle.net/10722/314271 |
ISSN | 2023 Impact Factor: 3.0 2023 SCImago Journal Rankings: 1.052 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, ST | - |
dc.contributor.author | Chau, PH | - |
dc.contributor.author | Lam, TC | - |
dc.contributor.author | Ng, YMA | - |
dc.contributor.author | Kwok, WHT | - |
dc.contributor.author | Takemura, N | - |
dc.contributor.author | Woo, J | - |
dc.contributor.author | Yu, SFD | - |
dc.contributor.author | Lin, C | - |
dc.date.accessioned | 2022-07-18T06:14:57Z | - |
dc.date.available | 2022-07-18T06:14:57Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Journal of Geriatric Oncology, 2022, v. 13, p. 682-690 | - |
dc.identifier.issn | 1879-4068 | - |
dc.identifier.uri | http://hdl.handle.net/10722/314271 | - |
dc.description.abstract | Objectives: To evaluate the feasibility and potential effects of qigong Baduanjin for reversing frailty status among older cancer survivors. Materials and Methods: Twenty-eight older cancer survivors screened as pre-frail or frail were recruited. They were randomly assigned (1:1) to receive a sixteen-week Baduanjin intervention or an active control condition (light flexibility exercise). Frailty status (primary outcome) and secondary outcomes (physical performance, activities of daily living performance, psychological well-being, and health-related quality of life) were measured by physical performance tests and questionnaires. Qualitative interviews were conducted to explore participants' perspectives on the intervention. Results: Twenty-one participants (75%) completed the study, with reasons of withdrawal mainly relating to the COVID-19 pandemic. Attendance at Baduanjin sessions and adherence to self-practice were satisfactory, with all retained participants attending all sessions and 81.8% practicing Baduanjin for more than 90 min per week. Qualitative findings demonstrated that participants accepted Baduanjin. The proportion of improvement in frailty status at post-intervention appeared to be higher in the intervention group (26.7%; 95% confidence interval [CI], 10.1% to 54.0%) than the control group (15.4%; 95% CI, 3.7% to 46.0%); yet the difference was not statistically significant (p = 0.461). Conclusions: Baduanjin qigong appears to be feasible and acceptable among older cancer survivors. To confirm the intervention effect, an adequately powered trial is warranted. Trial Registration: ClinicalTrials.gov, NCT04694066. Retrospectively registered 5 January 2021, https://clinicaltrials.gov/ct2/show/NCT04694066. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Geriatric Oncology | - |
dc.title | A pilot randomized controlled trial using Baduanjin qigong to reverse frailty status among post-treatment older cancer survivors | - |
dc.type | Article | - |
dc.identifier.email | Cheung, ST: denisest@hku.hk | - |
dc.identifier.email | Chau, PH: phpchau@hku.hk | - |
dc.identifier.email | Lam, TC: lamtc03@hku.hk | - |
dc.identifier.email | Ng, YMA: aymng@hku.hk | - |
dc.identifier.email | Yu, SFD: dyu1@hku.hk | - |
dc.identifier.email | Lin, C: lincc@hku.hk | - |
dc.identifier.authority | Cheung, ST=rp02526 | - |
dc.identifier.authority | Chau, PH=rp00574 | - |
dc.identifier.authority | Lam, TC=rp02128 | - |
dc.identifier.authority | Ng, YMA=rp02611 | - |
dc.identifier.authority | Yu, SFD=rp02647 | - |
dc.identifier.authority | Lin, C=rp02265 | - |
dc.identifier.doi | 10.1016/j.jgo.2022.02.014 | - |
dc.identifier.scopus | eid_2-s2.0-85125894349 | - |
dc.identifier.hkuros | 334105 | - |
dc.identifier.volume | 13 | - |
dc.identifier.spage | 682 | - |
dc.identifier.epage | 690 | - |
dc.identifier.isi | WOS:000851360600018 | - |